Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.
SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia.
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
Single-molecule analysis of cell surface dynamics in Caenorhabditis elegans embryos.
Oral 5-FU alternatives for the treatment of head and neck cancer.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Oral 5-FU alternatives for the treatment of head and neck cancer.
Oral 5-FU alternatives for the treatment of head and neck cancer. Oncology (Williston Park). 1998 Oct; 12(10 Suppl 7):35-8.
View in:
PubMed
subject areas
Administration, Oral
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Chemotherapy, Adjuvant
Etoposide
Fluorouracil
Head and Neck Neoplasms
Humans
Hydroxyurea
Neoplasm Recurrence, Local
Tegafur
Uracil
authors with profiles
Daniel Haraf
Bruce E. Brockstein